What to Expect From Edwards Lifesciences' Next Quarterly Earnings Report
By Bullbit Editorial · March 27, 2026
WhatEdwards Lifesciences is expected to report its Q1 2026 earnings on April 27, 2026, with analysts predicting revenue of **$1.65 billion**.
WhyThe company's performance will be influenced by the demand for its transcatheter heart valve products and the impact of any potential disruptions in the global supply chain.
SignalA beat in Q1 revenue could signal a strong start to the year for Edwards Lifesciences, potentially leading to an upward revision of its full-year guidance.
TargetThe company's Q1 earnings per share (EPS) are expected to be around **$1.45**, with a range of **$1.40** to **$1.50**.
RiskAny unexpected delays or setbacks in the development of new products, such as the Edwards SAPIEN 3 Ultra, could pose a risk to the company's revenue growth and profitability.